scholarly article | Q13442814 |
P50 | author | Rachel A Botting | Q89808438 |
Ashley Mansell | Q37376445 | ||
Anthony L. Cunningham | Q39034658 | ||
P2093 | author name string | Eve Diefenbach | |
Russell J Diefenbach | |||
Min Kim | |||
Najla Nasr | |||
Andrew N Harman | |||
Abdullateef A Alshehri | |||
Alexandra Feetham | |||
Ani Galoyan | |||
Bonnie M Hiener | |||
Dharshini Rambukwelle | |||
P2860 | cites work | Manipulation of dendritic cell function by viruses | Q21710678 |
Interferon-kappa, a novel type I interferon expressed in human keratinocytes | Q24291586 | ||
Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions | Q24301741 | ||
Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 | Q24318342 | ||
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx | Q24605940 | ||
Evolutionary conflicts between viruses and restriction factors shape immunity | Q27022032 | ||
Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation | Q27679261 | ||
NAK is an IkappaB kinase-activating kinase | Q28143033 | ||
IL-28 and IL-29: newcomers to the interferon family | Q28293519 | ||
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity | Q28510917 | ||
The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes | Q28534504 | ||
Interferon-ε protects the female reproductive tract from viral and bacterial infection | Q28586311 | ||
Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3 | Q28743826 | ||
TBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation | Q29030353 | ||
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity | Q29547722 | ||
Direct observation of individual endogenous protein complexes in situ by proximity ligation | Q29616032 | ||
Vaginal myeloid dendritic cells transmit founder HIV-1. | Q33744037 | ||
The macrophage in HIV-1 infection: from activation to deactivation? | Q33810779 | ||
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production | Q34009029 | ||
Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1. | Q34059146 | ||
Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV. | Q34059582 | ||
RIG-I-Mediated Antiviral Signaling Is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I | Q34150344 | ||
Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system | Q34155484 | ||
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells | Q34635742 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
Glycerol monolaurate prevents mucosal SIV transmission | Q34957016 | ||
The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase | Q35076546 | ||
SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex | Q35119171 | ||
Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice | Q35215887 | ||
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression | Q35564886 | ||
Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells | Q36172164 | ||
ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKε and TBK1 as an alternative substrate | Q36246350 | ||
The pivotal role of TBK1 in inflammatory responses mediated by macrophages | Q36469148 | ||
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation | Q36559594 | ||
Initial HIV mucosal infection and dendritic cells | Q36870081 | ||
R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5 | Q36870124 | ||
Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus | Q36930438 | ||
HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase | Q37262510 | ||
Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. | Q37269093 | ||
Interferons: signaling, antiviral and viral evasion | Q37342272 | ||
Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells | Q37365391 | ||
Relative resistance of HIV-1 founder viruses to control by interferon-alpha | Q37532983 | ||
IFN-λs | Q37917252 | ||
Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. | Q38080359 | ||
Tissue dendritic cells as portals for HIV entry | Q38125962 | ||
STING-dependent cytosolic DNA sensing pathways | Q38169005 | ||
Mechanisms underlying the inhibition of interferon signaling by viruses | Q38185897 | ||
Identification of lineage relationships and novel markers of blood and skin human dendritic cells | Q39238134 | ||
Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism | Q39347085 | ||
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilo | Q39717470 | ||
PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production | Q39924024 | ||
Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. | Q40416432 | ||
HIV-1 Vpu does not degrade interferon regulatory factor 3. | Q41993352 | ||
Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin | Q42203272 | ||
HIV infection of dendritic cells. | Q42259828 | ||
Possible role of phosphoinositide-3-kinase in Mx1 protein translation and antiviral activity of interferon-omega-stimulated HeLa cells | Q44190409 | ||
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. | Q44683563 | ||
M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. | Q47884316 | ||
Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans–T cell conjugates | Q59705671 | ||
Characterization of cultured microglia that can be infected by HIV-1 | Q73934630 | ||
HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells | Q79326773 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 6575-6584 | |
P577 | publication date | 2015-04-08 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1 | |
P478 | volume | 89 |
Q36889962 | Antiviral factors and type I/III interferon expression associated with regulatory factors in the oral epithelial cells from HIV-1-serodiscordant couples. |
Q58076945 | CD16 monocytes give rise to CD103RALDH2TCF4 dendritic cells with unique transcriptional and immunological features |
Q38806803 | Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity |
Q33618390 | Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway. |
Q57468964 | Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs |
Q39097804 | Dendritic Cell Immune Responses in HIV-1 Controllers |
Q90383136 | Dendritic Cell Maturation Regulates TSPAN7 Function in HIV-1 Transfer to CD4+ T Lymphocytes |
Q37675710 | Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. |
Q89935915 | Diverse effects of interferon alpha on the establishment and reversal of HIV latency |
Q36902474 | Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery. |
Q36080904 | HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3. |
Q57036795 | HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation |
Q40351539 | HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication |
Q89589282 | HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters |
Q39027389 | HIV-1-Mediated BAFF Secretion in Macrophages Does Not Require Endosomal TLRs, Type-I IFN, and Nef, but Depends on the Cellular Phenotype Status. |
Q40706800 | HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. |
Q92188956 | HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells |
Q92479178 | Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection |
Q54260280 | Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages. |
Q92948206 | Identification of HIV transmitting CD11c+ human epidermal dendritic cells |
Q92511221 | Illuminating the Role of Vpr in HIV Infection of Myeloid Cells |
Q55254424 | Immune Ecosystem of Virus-Infected Host Tissues. |
Q38862108 | Innate immune evasion strategies of DNA and RNA viruses |
Q90733129 | Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events |
Q64076810 | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
Q40097513 | Mechanism of Interferon Stimulated Gene Induction in HIV-1 Infected Macrophages |
Q33694145 | Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes |
Q40062891 | Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation |
Q90483351 | Regulation of cGAS-Mediated Immune Responses and Immunotherapy |
Q64910872 | Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection. |
Q40207016 | Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages. |
Q92853738 | Sensor Sensibility-HIV-1 and the Innate Immune Response |
Q89603081 | Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent cell death |
Q90167804 | The E3 Ubiquitin Ligase TBK1 Mediates the Degradation of Multiple Picornavirus VP3 Proteins by Phosphorylation and Ubiquitination |
Q45324456 | The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection |
Q40305499 | Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells |
Q38773128 | Viral evasion of DNA-stimulated innate immune responses |
Search more.